UQ staff honoured in 2006 Australia Day awards
...ded the establishment of one of the first start-up biotechnology companies in Australia in the 1980s as well as chairing the Moreton Bay Waterways Partnership, which over the past 10 years has become the national benchmark for how to manage waterways. Professor Greenfield was also named as one of Australia's 100 ...GlycoFi announces the first production of antibodies with human glycosylation in yeast
...of the largest selling products to emerge from the biotechnology industry. Monoclonal antibodies often achieve their therapeutic benefit through two binding events: 1) the binding of the variable domain of the antibody to a specific marker protein, such as the CD20 receptor on the surface of cancer cells, followed...Dartmouth, GlycoFi researchers make leap in protein bioengineering
...g, the Dartmouth-Hitchcock Medical Center, and the biotechnology firm GlycoFi, Inc., report a breakthrough in using yeast to produce antibodies with human sugar structures. Antibodies are proteins with sugars attached to them, and they are emerging as a major class of drugs in the treatment of cancer. In the glob...The closest look ever at the cell's machines
... S. cerevisiae (baker's yeast). The study from the biotechnology company Cellzome, in collaboration with the European Molecular Biology Laboratory (EMBL), appears in this week's online edition of Nature. "To carry out their tasks, most proteins work in dynamic complexes that may contain dozens of molecules," says ...Gene-specific Ebola therapies protect non-human primates from lethal disease
...formed in collaboration with AVI BioPharma, a U.S. biotechnology firm. According to the study's authors, antisense drugs are useful against viral diseases because they are designed to enter cells and eliminate viruses by preventing their replication. The drugs, which act by blocking critical viral genetic sequence...Plant-derived vaccines safeguard against deadly plague
Through an innovative feat of plant biotechnology and vaccine design, researchers in the Biodesign Institute at Arizona State University have successfully turned tobacco plants into vaccine production factories to combat the deadliest form of plague. The vaccine elicits a protective immune response ...Conference explores use of microbes in nanotechnology
...topics to be covered include: Using bacteria and biotechnology to manufacture microscopic electronic devices Developing interfaces between biological materials and nano-structures for applications such as disease detection, monitoring and control. Using bacteria and other biological materials for information p...Conference to address the challenge of renewable resources
...le Feedstocks for chemical manufacture Industrial biotechnology and bioprocessing Carbohydrates and Oleochemicals New Materials and Products based on Renewable Resources Biofuels and Bio-energy Sustainability of the use of renewable resources Investment Professor James Clark, of the York event's organising c...UCF, NIH study: Effective, safe anthrax vaccine can be grown in tobacco plants
...es, began teaching at UCF in 1998. He has formed a biotechnology company called Chlorogen to apply his work in chloroplast genetic engineering. In 2004, he won UCF's Pegasus Professor Award, the top honor given to a faculty member who excels in teaching, research and service. Last year, he also became only the 14t...Interim Aranesp data suggest major response in anemic patients with MDS
..., 2005) Amgen (NASDAQ: AMGN), the world's largest biotechnology company, today announced updated interim data from a Phase 2 study evaluating the use of 500 mcg of Aranesp darbepoetin alfa) administered every three weeks to treat anemia in patients with a bone marrow disorder known as myelodysplastic syndrome (MD...Interim long-term follow-up data show AMG 531 increases platelets in patients with ITP
..., 2005) Amgen (NASDAQ: AMGN), the world's largest biotechnology company, today announced interim results from an open-label study showing that long-term administration (up to 48 weeks) of its investigational therapy AMG 531 was generally well-tolerated and stimulated platelet production in patients with immune th...New Phase 3 data show potential benefits of Aranesp dosed every three weeks for CIA
..., 2005) Amgen (NASDAQ: AMGN), the world's largest biotechnology company, today announced interim results from the first multi-center, randomized, double-blind, placebo-controlled, Phase 3 trial of Aranesp (darbepoetin alfa) administered every three weeks in cancer patients with chemotherapy-induced anemia. The s...Toxicology-on-a-chip tool readies for market
...he technology for the end user: pharmaceutical and biotechnology companies. The researchers are working to bring the MetaChip to market within a year. "Compounds can be screened early, quickly, and effectively by the MetaChip to prevent toxic drugs from getting through the discovery process, being put on the marke...Mouse study: New muscle-building agent beats all previous ones
...veloped, with pharmaceutical company Wyeth and the biotechnology firm MetaMorphix, an agent that's more effective at increasing muscle mass in mice than a related potential treatment for muscular dystrophy now in clinical trials. The new agent is a version of a cellular docking point for the muscle-limiting protei...The World Economic Forum announces new class of technology pioneers for 2006: Ossur selected
...nd innovative technologies in the areas of energy, biotechnology and health, and information technology. This year's class of companies has been selected not only because of the cutting-edge work undertaken by the organizations, but also because their work has potential long-term impact on business and society. In...Scientists pool information to boost understanding of drug action
...ct has sparked a huge effort by pharmaceutical and biotechnology companies worldwide to identify new drug targets and much of this effort has focused on the GPCRs. Our knowledge of this branch of science has advanced very rapidly and it has been difficult for scientists engaged in research in the field and in the ...New technique multiplies life span in simple organisms
...nto anti-agingdrug development programs at several biotechnology companies. Now, molecular geneticists at the University of Southern Californiasuggest that SIR2 instead promotes aging. Their study, "Sir2 Blocks Extreme Life-Span Extension," appearsin the Nov. 18 edition of the biology journal Cell. The lead author...Battle to beat the bugs wins bio-firm top honour
...ct of the Year in 2004 has helped transform a good biotechnology project into a new start-up company," said Dr Dobs...o the companies and organisations that make up the biotechnology cluster. "[The industry] employs more than 20,000 people in the northwest; it is only right, therefo...Leading researchers from Israel and Southern California to present stem cell symposium
...ational Institutes of Health. Representatives from biotechnology laboratories in Israel will speak on these topics: Neuronal Differentiation from Cultured Embryonic and Adult Stem Cells Immune-based Therapies for Spinal Cord Injury and Stroke Autologous Transplantation of Bone Marrow Stem Cells for Parkinson's......son's Focus on the Family. "The rapid advance of biotechnology is quickly outpacing our ability as a society to absorb the effect it will have on our lives," said Kathryn Hinsch, founder of the Women's Bioethics Project and author of the report, "The institutions we have relied on for guidance on difficult moral...